One of Wales leading life sciences firms, Creo Medical, has reported a near tripling in revenues and a collaboration agreement with a global leader in robotic- assisted surgery.
The Chepstow-based Alternative Investment Market listed firm, which is developing and commercialising a suite of electrosurgical medical devices in the field of surgical endoscopy, has reported revenues of £25.2m for 2021 compared to £9.4m a year earlier.
Creo, which in line with expectations posted operational losses of £29.9m, has also struck a collaboration agreement with US and Nasdaq listed Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery.
